Home
 /
Papers
 /
Cell Biology
 /
Subcellular transcriptome sequencing with single cell APEX-seq identifies regulators of cell-cell interactions
Preprint
Open access
V1
Top 1% · Validated by QED

Subcellular transcriptome sequencing with single cell APEX-seq identifies regulators of cell-cell interactions

Andrew Xue, Bo Cai, Qian Xue +4 more
March 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.03.17.712496
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Cell Biology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By resolving where RNAs live within individual cells, scAPEX-seq exposes cell–cell interaction programs and CAR T states that standard sequencing cannot see, identifying CTSW overexpression as a strategy to sustain antitumor immunity.

QED claims analysis

Summary

Single-cell APEX-seq (scAPEX-seq) enables subcellular transcriptome profiling at single-cell resolution by enriching endoplasmic reticulum-associated transcripts, revealing interaction-dependent cell states in tumor-immune cell co-cultures that are missed by conventional scRNA-seq and identifying CTSW as a regulator that promotes CAR T cell persistence and sustained tumor killing through maintenance of stem-like memory phenotypes.

See full analysis
Main Claim 1 –

APEX-seq2 Achieves 10-Fold Higher RNA Recovery with Specificity

Supporting evidence

  • APEX-seq2 Preserves Spatial Specificity Across Compartments with Less Input
Main Claim 2 –

scAPEX-seq Detects Interaction-Dependent Cell States Missed by scRNA-seq

Main Claim 3 –

scAPEX-seq Resolves Early CAR T Activation States After Tumor Contact

Supporting evidence

  • Early scAPEX-seq CAR T States Predict Long-Term Effector Persistence
  • Rapid NT5E Induction Limits CAR T Persistence After Tumor Contact
Main Claim 4 –

CTSW Overexpression Sustains CAR T Stemness, Persistence, and Tumor Killing

Abstract

Single-cell RNA sequencing has transformed our understanding of tissue complexity and heterogeneous cell states, yet provides little information about the subcellular organization of transcriptomes - despite the central role of RNA localization in splicing, translation, and function. Here we introduce single-cell APEX-seq (scAPEX-seq), a proximity labeling-based method for mapping subcellular transcriptomes at single-cell resolution. Improvements in probe design and RNA recovery enable APEX integration with droplet-based RNA-seq to capture endoplasmic reticulum–associated transcripts from thousands of individual cells. Applied to tumor–macrophage co-cultures, ER-targeted scAPEX-seq revealed interaction-dependent cell states and transcriptomic signatures by enriching for cell surface and secretory transcripts that are poorly resolved by conventional scRNA-seq. We further applied scAPEX-seq to short- and long-term co-cultures of HER2+ tumor cells with human chimeric antigen receptor (CAR) T cells, resolving distinct activated CAR T cell states, including populations characterized by upregulated NT5E or CTSW expression. We showed that overexpression of CTSW, a cathepsin protease, in CAR T cells promotes stem-like phenotypes, long-term proliferation, and sustained tumor cell killing. scAPEX-seq provides a powerful and scalable approach for profiling subcellular RNA populations, enabling the discovery of cell-cell interaction regulators missed by conventional approaches.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?